๎
๊ฒ์
์์ฅ
๋ด์ค
๋ถ์
๋๊ตฌ
์ข ๋ชฉ ์คํฌ๋ฆฌ๋
๋ ์์๋ณด๊ธฐ
๎ผ
์ค์บํ์ฌ ๋ค์ด๋ก๋
๋จ ํ๋์ ํ์ ์ค์ฝ์ด. ๋ ์ค๋งํธํ ํฌ์ ๊ฒฐ์ .
๎
English
็นไฝไธญๆ
เนเธเธข
Tiแบฟng viแปt
็ฎไฝไธญๆ
Espaรฑol
Portuguรชs
Deutsch
ํ๊ตญ์ด
๎ณ
ๆฅๆฌ่ช
๋ก๊ทธ์ธ
๋ฌด๋ฃ ํ์๊ฐ์
๎
๊ฒ์
๋ฌด๋ฃ ํ์๊ฐ์
๎
๎
์์ฅ๊ฐ
/
์ฃผ์
/
nasdaq-rapp
/
Rapport Therapeutics Inc
RAPP
๎ญ
๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
39.390
USD
-2.280
-5.47%
์ข ๊ฐย 07/01, 16:00๏ผET๏ผ
์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
0.000
USD
0.000
์ฅ์ ๊ฑฐ๋ย 07/02, 09:30ย (ET)
1.88B
์๊ฐ์ด์ก
์์ค
P/E TTM
Rapport Therapeutics Inc
39.390
-2.280
-5.47%
๊ฐ์
๊ธ์ต
ํ ๋ก
๋ถ์
ํ์ฌ
ํ๋กํ
์์ต
์ฃผ์ฃผ
๊ธฐ์
๊ฐ์
๊ธ์ต
ํ ๋ก
๋ถ์
ํ์ฌ
ํ๋กํ
์์ต
์ฃผ์ฃผ
๊ธฐ์
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Mon, May 11
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Mon, May 11
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
๊ธฐํ
48.41%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Third Rock Ventures, LLC
15.48%
Fidelity Management & Research Company LLC
14.87%
ARCH Venture Partners
7.80%
Capital International Investors
7.11%
Cormorant Asset Management, LP
6.33%
๊ธฐํ
48.41%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
44.45%
Venture Capital
31.60%
Investment Advisor/Hedge Fund
12.72%
Hedge Fund
12.70%
Individual Investor
4.65%
Research Firm
4.37%
Private Equity
1.41%
Bank and Trust
0.43%
Pension Fund
0.15%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Wed, Apr 1
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Wed, Apr 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q1
264
57.38M
119.98%
+6.40M
2025Q4
222
49.73M
104.33%
+9.58M
2025Q3
166
42.95M
90.12%
+1.16M
2025Q2
154
43.38M
118.86%
+3.70M
2025Q1
149
47.96M
131.36%
+9.87M
2024Q4
117
46.27M
126.51%
+9.23M
2024Q3
91
39.09M
106.87%
+12.18M
2024Q2
48
37.49M
102.49%
+37.49M
์ฃผ์ฃผ ํ๋
๎
์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Third Rock Ventures, LLC
8.10M
17%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
6.92M
14.51%
+1.44M
+26.35%
Sep 30, 2025
ARCH Venture Partners
3.73M
7.82%
--
--
Sep 30, 2025
Capital International Investors
3.40M
7.14%
+800.00K
+30.74%
Sep 30, 2025
Cormorant Asset Management, LP
3.19M
6.7%
+251.60K
+8.56%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.42M
2.97%
+354.67K
+33.41%
Sep 30, 2025
Sofinnova Investments, Inc
1.95M
4.09%
-48.02K
-2.41%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.63M
3.43%
+397.43K
+32.18%
Sep 30, 2025
Johnson & Johnson Innovation-JJDC, Inc.
1.78M
3.74%
-713.53K
-28.56%
Sep 30, 2025
Baker Bros. Advisors LP
1.55M
3.25%
+997.00K
+181.24%
Sep 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Tue, Dec 2
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Tue, Dec 2
์ด๋ฆ
๋น์จ
Virtus LifeSci Biotech Clinical Trials ETF
1.76%
iShares Neuroscience and Healthcare ETF
0.84%
ALPS Medical Breakthroughs ETF
0.43%
Invesco Nasdaq Biotechnology ETF
0.1%
iShares Micro-Cap ETF
0.1%
ProShares Ultra Nasdaq Biotechnology
0.1%
Avantis US Small Cap Equity ETF
0.06%
iShares Biotechnology ETF
0.06%
Vanguard US Momentum Factor ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
๋ ๋ณด๊ธฐ
Virtus LifeSci Biotech Clinical Trials ETF
๋น์จ
1.76%
iShares Neuroscience and Healthcare ETF
๋น์จ
0.84%
ALPS Medical Breakthroughs ETF
๋น์จ
0.43%
Invesco Nasdaq Biotechnology ETF
๋น์จ
0.1%
iShares Micro-Cap ETF
๋น์จ
0.1%
ProShares Ultra Nasdaq Biotechnology
๋น์จ
0.1%
Avantis US Small Cap Equity ETF
๋น์จ
0.06%
iShares Biotechnology ETF
๋น์จ
0.06%
Vanguard US Momentum Factor ETF
๋น์จ
0.04%
iShares Russell 2000 Value ETF
๋น์จ
0.03%